Tradipitant for Functional Dyspepsia

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Xiao Jing (Iris) Wang
Study ID
NCT05653310
Phase
PHASE2
Status
Enrolling By Invitation

Conditions

  • Functional Dyspepsia

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • Tradipitant — DRUG
    Tradipitant Capsule
  • Placebo — DRUG
    Placebo Capsule

Study Details

To evaluate the effects of tradipitant relative to placebo on gastric motor functions, satiation, and postprandial symptoms in patients with functional dyspepsia.

Key Dates

Start date
Feb 9, 2023
Status verified
Jan 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Tradipitant
    Oral Capsule
  • Placebo Comparator: Placebo
    Oral Capsule

Primary Outcome Measure

Accommodation gastric volumes measured by single photon emission computed tomography (SPECT) [ Time Frame: 4 Weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in MinnesotaRochesterMinnesota55905-

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Minnesota· Rochester, MN

Related Studies